The motivations, barriers, and sociodemographic characteristics of healthy Chinese volunteers in phase I research

被引：0
|
作者：
Zejuan Wang
Gang Chen
Xiaona Liu
Chen Liu
Qingkun Song
Jin Wang
机构：
[1] Aerospace Center Hospital,Department of Clinical Pharmacology
[2] Capital Medical University,Phase I Clinical Trial Centre, Beijing Shijitan Hospital
[3] Capital Medical University,Department of Science and Technology, Beijing Shijitan Hospital
来源：
European Journal of Clinical Pharmacology | 2021年 / 77卷
关键词：
Healthy volunteers; Recruitment; Participation; Motivations; Barriers; Willingness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：557 / 568
页数：11
相关论文
共 50 条
  • [1] The motivations, barriers, and sociodemographic characteristics of healthy Chinese volunteers in phase I research
    Wang, Zejuan
    Chen, Gang
    Liu, Xiaona
    Liu, Chen
    Song, Qingkun
    Wang, Jin
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (04) : 557 - 568
  • [2] Characteristics, Motivations, and Preferences of Healthy Volunteers in Phase I Clinical Trials in Sweden
    Rein-Hedin, Erik
    Schultzberg, Marten
    Sjoberg, Folke
    Huss, Fredrik
    JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 2025,
  • [3] Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time
    Kalbaugh, Corey A.
    Kalbaugh, Julianne M.
    McManus, Lisa
    Fisher, Jill A.
    PLOS ONE, 2021, 16 (09):
  • [4] Motivations, enrollment decisions, and socio-demographic characteristics of healthy volunteers in phase 1 research
    Grady, Christine
    Bedarida, Gabriella
    Sinaii, Ninet
    Gregorio, Mark Anthony
    Emanuel, Ezekiel J.
    CLINICAL TRIALS, 2017, 14 (05) : 526 - 536
  • [5] Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time (vol 16, e0256994, 2021)
    Kalbaugh, C. A.
    Kalbaugh, J. M.
    McManus, L.
    Fisher, J. A.
    PLOS ONE, 2022, 17 (01):
  • [6] Phase I safety, tolerability, and pharmacokinetic studies of tetramethylpyrazine nitrone in healthy Chinese volunteers
    Zhao, Caiyun
    Lv, Yuan
    Cui, Hong
    Zhu, Yan
    Wei, Minji
    Xia, Yahong
    Tian, Jihong
    Ma, Yan
    Liu, Yan
    Zhang, Pu
    Wang, Xi
    Wu, Jing
    Wang, Yatai
    DRUG DEVELOPMENT RESEARCH, 2021, 82 (01) : 97 - 107
  • [7] A phase I study of monohydroxyethylrutoside in healthy volunteers
    Anja M. Willems
    Anne M. Bruynzeel
    Marc A. Kedde
    Cees J. van Groeningen
    Aalt Bast
    Wim J. van der Vijgh
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 678 - 684
  • [8] A phase I study of monohydroxyethylrutoside in healthy volunteers
    Willems, AM
    Bruynzeel, AM
    Kedde, MA
    van Groeningen, CJ
    Bast, A
    van der Vijgh, WJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (05) : 678 - 684
  • [9] A Study on the Characteristics of Healthy Volunteers who Participate in Phase I Clinical Trials in Korea
    Seo, Ji-Hye
    Kim, Ock-Joo
    Yoo, Sang-Ho
    Choi, Eun Kyung
    Park, Ji-Eun
    JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 2022, 17 (1-2) : 193 - 212
  • [10] A Phase I study to evaluate the pharmacokinetics of axitinib (AG-13736) in healthy Chinese volunteers
    Chen, Y.
    Jiang, J.
    Zhang, J.
    Tortorici, M. A.
    Pithavala, Y. K.
    Lu, L.
    Ni, G.
    Hu, P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (11) : 679 - 687
12345